Provided are a macromolecular material excellent in mechanical strength and a production method therefor. A macromolecular material of the present invention has a structure crosslinked through host-guest interaction, and is obtained by a method including: a step of preparing a mixture of a host-group-containing macromolecular compound swollen or dissolved in a solvent and a guest-group-containing macromolecular compound swollen or dissolved in a solvent; and a step of mechanically kneading the mixture. As another aspect, a macromolecular material of the present invention is obtained by a method including: a step of swelling or dissolving a both host-group- and guest-group-containing macromolecular compound in a solvent; and a step of mechanically kneading the swollen or dissolved macromolecular compound.

A method for the production of hyperbranched polyacrylates includes the step of reacting acrylic inimers through controlled living polymerization in aqueous conditions. The inimers may have the formula: ##STR00001##
Wherein X is a halogen, a thiocarbonylthio or nitroxide group, and R is hydrogen, methyl, dodecyl, and groups containing mesogenin substituents, fluorocarbon substituents, siloxane substituents and oxyethylene substituents. In particular, the aqueous condition is emulsion or miniemulsion. The polymerization may be reverse ATRP, SN&RI and AGET polymerization or RAFT polymerization (with thiocarbonylthio X groups) or nitroxide mediated polyeization (with nitroxide X groups).

The present invention provides compositions of a therapeutic agent and a polymeric stabilizing agent for stabilizing the reservoir of an implantable drug delivery system. The present invention also includes an implantable drug delivery system incorporating the composition of the present invention, as well as methods of treating diabetes using the compositions and implantable drug delivery system of the present invention.

The present invention relates to a macromolecule comprising a dendrimer having surface amino groups to which at least two different terminal groups are attached including a pharmaceutically active agent and a pharmacokinetic modifying agent, the pharmaceutically active agent comprising a hydroxyl group and being attached to the surface amino group of the dendrimer through a diacid linker. Pharmaceutical compositions comprising the macromolecules and methods of treatment using the macromolecules are also described.

An ordered macroporous metal-organic framework single crystals and a preparation method therefor. In the method, a three-dimensional structure constructed by polymer microspheres is used as a template; 2-methylimidazole and zinc nitrate, precursors of MOFs, are firstly deposited in the three-dimensional template; the three-dimensional template containing the precursors is soaked in a mixed solution of ammonia water and methanol subsequently, and the three-dimensional template is taken out after crystallization; the three-dimensional template is soaked in an organic solvent to remove the macromolecular three-dimensional template, and the ordered macroporous MOF single crystals is obtained through centrifugal separation. The ordered macroporous MOF single crystals have a basic framework of zeolitic imidazolate framework-8, and structurally include highly-ordered macro-pores whose pore size may be controlled to be between 50 and 2000 nm based on a size of the used template.

Compositions may include those of the formula: (I) wherein R1 is an alkyl chain having a carbon number in the range of greater than 40 to 200, R2 is a multiester, R3 is hydrogen, an ion, or an alkyl chain having a carbon number in the range of 1 to 200, m is an integer selected from 0 to 4, and n is an integer selected from the range of 0 to 4, wherein the sum of m and n is 1 or greater. Compositions may include a reaction product of a polyisobutylene-substituted succinic anhydride and a hydroxy-functional dendrimer, wherein the molar ratio of polyisobutylene-substituted succinic anhydride to hydroxy-functional dendrimer is within the range of 10:1 to 30:1.

##STR00001##

This document describes biochemical pathways for producing adipyl-[acp] and either hexanoic acid or acetic acid from a long chain acyl-[acp] such as dodecanoyl-[acp] or octanoyl-[acp] using a polypeptide having pimeloyl-[acp] synthase activity and biochemical pathways for converting adipyl-[acp] and/or hexanoic acid to one of more of adipic acid, 6-aminohexanoic acid, 6-hydroxyhexanoic acid, hexamethylenediamine, caprolactam, and 1,6-hexanediol.

This document describes biochemical pathways for producing adipyl-[acp] and either hexanoic acid or acetic acid from a long chain acyl-[acp] such as dodecanoyl-[acp] or octanoyl-[acp] using a polypeptide having pimeloyl-[acp] synthase activity and biochemical pathways for converting adipyl-[acp] and/or hexanoic acid to one of more of adipic acid, 6-aminohexanoic acid, 6-hydroxyhexanoic acid, hexamethylenediamine, caprolactam, and 1,6-hexanediol.

Provided is a self-restoring macromolecular material that not only has excellent stress relaxation but that can also be easily restored to its original state, even when damaged or severed. Also provided is a method for producing the self-restoring macromolecular material. The self-restoring macromolecular material contains a crosslinked structure that is formed by crosslinking a polymer containing at least a polyrotaxane molecule. The polyrotaxane molecule is formed so as to include a cyclic molecule 21 and a linear molecule that passes through an opening 21a of the cyclic molecule. The crosslinked structure 1 is crosslinked via a reversible bond between the cyclic molecule of the polyrotaxane molecule and a polymer molecule other than the polyrotaxane molecule.

The present invention relates to, in general, methods of fabricating a covalent organic framework (COF) and the COF thereof. In particular, the method comprises forming an acylhydrazone bond with an optionally substituted 2-alkoxybenzohydrazidyl moiety. The resultant COF has an x-ray diffraction 2-theta peak at about 3° with a full width half maximum (FWHM) of about 0.2° to about 0.4°.